Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

GREEN360 TECHNOLOGIES LIMITED Interim / Quarterly Report 2017

Jul 27, 2017

65020_rns_2017-07-27_a7cc0a06-0da5-4f8c-bdbc-e6408d4f9abe.pdf

Interim / Quarterly Report

Open in viewer

Opens in your device viewer

June 2017 Quarterly Report

==> picture [137 x 72] intentionally omitted <==

ASX Release

==> picture [123 x 10] intentionally omitted <==

28 July 2017

ULTRACHARGE LIMITED ACN 140 316 463

Level 6

105 St Georges Terrace, Perth Western Australia 6000 Tel: +61 8 6558 0886 Fax: +61 8 6316 3337 Web: www.ultra-charge.net

==> picture [123 x 10] intentionally omitted <==

Corporate and Investors Armada Capital & Equities Michael Shaw-Taylor M: +61 477 383 390 D: +61 2 9276 1203 [email protected]

==> picture [123 x 9] intentionally omitted <==

Directors

Mr Kobi Ben-Shabat Mr David Wheeler Mr Doron Nevo Mr Yuri Nehushtan Mr John Paitaridis

ASX Code : UTR Shares : 451,407,126 Escrow Shares: 184,110,995 Options (various) : 82,000,000 Performance Rights: 41,250,000

==> picture [10 x 766] intentionally omitted <==

  • Strong progress made on the technical aspects of developing UltraCharge’s anode technology

  • Research project with Leclanche SA received $160,000 grant

  • Joint Israeli-Singapore initiative received US$1 million conditional grant offer

UltraCharge Limited ( ASX: UTR, UltraCharge or the Company ) is pleased to provide an operational update to accompany its Appendix 4C, released today, for the 3- month period to the 30 June 2017.

Corporate

UltraCharge made significant achievements this quarter, including progress on its pilot project with Swiss battery storage supplier Leclanche SA. The pilot project received a $160,000 grant from the Ministry of Economy of Israel for proof of concept, which accounts for 50% of the total project costs.

Further to this, UltraCharge in collaboration with Nanyang Technology University received a US$1M conditional grant offer, pending finalisation of collaboration terms, for a project to fast track and develop on UltraCharge’s anode technology, to produce a more superior anode that has extra battery power and energy capacity.

Technology update

UltraCharge made considerable progress with its core titanium dioxide nanotube technology, which can potentially replace graphite anodes in lithium batteries, producing a safer, longer lifetime and faster charging battery.

The Company has made significant progress in reproducing its titanium dioxide nanotubes to be able to deliver pilot batches and has engaged in end user discussions and testing of its materials with batches of test materials expected to be shipped in the next few months.

UltraCharge has also made progress on improving its core technology, increasing the anode capacity, while maintaining safety and fast charging features. These developments to the core technology will ensure UltraCharge remains competitive on the global marketplace.

Kobi Ben-Shabat, CEO said “I am pleased at the Company’s performance this quarter. Our research is world class and has been recognized by both the Israeli and Singaporean governments, reflected in the grants we have secured to date for our research programs. We are making good progress on the production and optimization of our patented nanotube technology for lithium ion batteries and are working with end users with the aim of securing a partnership or licensing agreement to produce commercial quantities of the anode technology”.

Kobi Ben-Shabat Chief Executive Officer

About Ultracharge Limited ( www.ultra-charge.net)

UltraCharge is a battery technology company based in Israel which has acquired exclusive rights to patented technology from the Nanyang Technology University in Singapore (NTU). The technology will replace graphite in anodes (negative pole) with a nanotube gel material made from titanium dioxide, in lithium batteries. This has the potential to revolutionise the market for lithium batteries by producing a battery that is safe, has a longer lifetime and is fast charging. UltraCharge has established a laboratory facility in Israel to conduct nanotube synthesis and fabrication of the nanotube anode, and is discussing supply options with end users in the global battery market

Appendix 4C Quarterly report for entities subject to Listing Rule 4.7B

+Rule 4.7B

Appendix 4C

Quarterly report for entities subject to Listing Rule 4.7B

Introduced 31/03/00 Amended 30/09/01, 24/10/05, 17/12/10, 01/09/16

Name of entity

UltraCharge Limited (formerly Lithex Resources Ltd)

ABN

Quarter ended (“current quarter”)

97 140 316 463

30 June 2017

Consolidated statement of cash flows Current quarter
$US’000
Year to date (12
months)
$US’000
1.
Cash flows from operating activities
1.1
Receipts from customers
1.2
Payments for
(a) research and development
(b) product manufacturing and operating
costs
(c) advertising and marketing
(d) leased assets
(e) staff costs – research and development
(f)
administration and corporate costs
1.3
Dividends received (see note 3)
1.4
Interest received
1.5
Interest and other costs of finance paid
1.6
Income taxes paid
1.7
Government grants and tax incentives
1.8
Other (provide details if material)
1.9
Net cash from / (used in) operating
activities
-
(293)
-
(66)
-
(140)
(303)
-
3
-
-
-
-
-
(1,039)
-
(90)
-
(536)
(945)
-
7
(3)
-
-
(2)
(799) (2,608)

On 2 December 2016, UTR completed the acquisition of UltraCharge Ltd (UltraCharge), an Israeli technology based company by issuing 485,900,000 shares and 57,500,000 performance rights in UTR. In accordance with the Accounting Standards the acquisition of Ultracharge has been accounted for as a reverse acquisition transaction under the guidelines and principles of AASB 2 Share Based Payments. As a result, the statement of cash flows comprises the cash transactions for Ultracharge (and its group entities) for the full period and the cash transactions of UTR from the date of acquisition being 2 December 2016 to the period ended 31 March 2017.

  • See chapter 19 for defined terms 1 September 2016

Page 1

Appendix 4C Quarterly report for entities subject to Listing Rule 4.7B

Consolidated statement of cash flows Current quarter
$US’000
Year to date (12
months)
$US’000
2.
Cash flows from investing activities
2.1
Payments to acquire:
(a) property, plant and equipment
(b) businesses (see item 10)
(c) investments
(d) intellectual property
(e) other non-current assets
2.2
Proceeds from disposal of:
(a) property, plant and equipment
(b) businesses (see item 10)
(c) investments
(d) intellectual property
(e) other non-current assets
2.3
Cash flows from loans to other entities
2.4
Dividends received (see note 3)
2.5
Other (provide details if material)
Proceeds from acquisition of Lithex
Resources Limited (the deemed acquiree
for accounting purposes)
2.6
Net cash from / (used in) investing
activities
-
-
-
-
-
-
-
-
-
-
-
-
-
(33)
-
-
-
-
-
-
-
-
-
95
-
1,163
- 1,225
3.
Cash flows from financing activities
3.1
Proceeds from issues of shares
3.2
Proceeds from issue of convertible notes
3.3
Proceeds from exercise of share options
3.4
Transaction costs related to issues of
shares, convertible notes or options
3.5
Proceeds from borrowings
3.6
Repayment of borrowings
3.7
Transaction costs related to loans and
borrowings
3.8
Dividends paid
3.9
Other (provide details if material)
3.10
Net cash from / (used in) financing
activities
-
-
-
-
-
-
-
-
-
3,232
-
-
(436)
-
-
-
-
-
- 2,796
  • See chapter 19 for defined terms 1 September 2016

Page 2

Appendix 4C Quarterly report for entities subject to Listing Rule 4.7B

Consolidated statement of cash flows Current quarter
$US’000
Year to date (12
months)
$US’000
4.
Net increase / (decrease) in cash and
cash equivalents for the period
4.1
Cash and cash equivalents at beginning of
quarter/year to date
4.2
Net cash from / (used in) operating
activities (item 1.9 above)
4.3
Net cash from / (used in) investing activities
(item 2.6 above)
4.4
Net cash from / (used in) financing activities
(item 3.10 above)
4.5
Effect of movement in exchange rates on
cash held
4.6
Cash and cash equivalents at end of
quarter
2,637
(799)
-
-
23
278
(2,608)
1,225
2,796
170
1,861 1,861
5.
Reconciliation of cash and cash
equivalents
at the end of the quarter (as shown in the
consolidated statement of cash flows) to the
related items in the accounts
Current quarter
$US’000
Previous quarter
$US’000
5.1
Bank balances
5.2
Call deposits
5.3
Bank overdrafts
5.4
Other (provide details)
5.5
Cash and cash equivalents at end of
quarter (should equal item 4.6 above)
1,861
-
-
-
2,637
-
-
-
1,861 2,637
6.
Payments to directors of the entity and their associates
Current quarter
$US'000
6.1
Aggregate amount of payments to these parties included in item 1.2
90
6.2
Aggregate amount of cash flow from loans to these parties included
in item 2.3
-
6.3
Include below any explanation necessary to understand the transactions included in
items 6.1 and 6.2
Current quarter
$US'000
90
-
Payments to related parties are for salaries and directors’ fees.
  • See chapter 19 for defined terms 1 September 2016

Page 3

Appendix 4C Quarterly report for entities subject to Listing Rule 4.7B

7. Payments to related entities of the entity and their Current quarter
associates $US'000
7.1 Aggregate amount of payments to these parties included in item 1.2 -
7.2 Aggregate amount of cash flow from loans to these parties included -
in item 2.3
7.3 Include below any explanation necessary to understand the transactions included in
items 7.1 and 7.2
8.
Financing facilities available
Add notes as necessary for an
understanding of the position
Total facility amount
at quarter end
$US’000
Amount drawn at
quarter end
$US’000
8.1
Loan facilities
-
-
8.2
Credit standby arrangements
-
-
8.3
Other (please specify)
-
-
8.4
Include below a description of each facility above, including the lender, interest rate and
whether it is secured or unsecured. If any additional facilities have been entered into or are
proposed to be entered into after quarter end, include details of those facilities as well.
Total facility amount
at quarter end
$US’000
Amount drawn at
quarter end
$US’000
- -
- -
- -
9.
Estimated cash outflows for next quarter
$US’000
9.1
Research and development
9.2
Product manufacturing and operating costs
9.3
Advertising and marketing
9.4
Leased assets
9.5
Staff costs – research and development
9.6
Administration and corporate costs
9.7
Other (provide details if material)
9.8
Total estimated cash outflows
147
-
48
-
154
338
-
687
  • See chapter 19 for defined terms 1 September 2016

Page 4

Appendix 4C Quarterly report for entities subject to Listing Rule 4.7B

10.
Acquisitions and disposals of
business entities
(items 2.1(b) and 2.2(b) above)
Acquisitions Disposals
10.1
Name of entity
10.2
Place of incorporation or
registration
10.3
Consideration for acquisition or
disposal
10.4
Total net assets
10.5
Nature of business

Compliance statement

  • 1 This statement has been prepared in accordance with accounting standards and policies which comply with Listing Rule 19.11A.

  • 2 This statement gives a true and fair view of the matters disclosed.

==> picture [81 x 55] intentionally omitted <==

Sign here: ............................................................ Date: 28 July 2017 (Company Secretary)

Print name: Peter Webse

Notes

  1. The quarterly report provides a basis for informing the market how the entity’s activities have been financed for the past quarter and the effect on its cash position. An entity that wishes to disclose additional information is encouraged to do so, in a note or notes included in or attached to this report.

  2. If this quarterly report has been prepared in accordance with Australian Accounting Standards, the definitions in, and provisions of, AASB 107: Statement of Cash Flows apply to this report. If this quarterly report has been prepared in accordance with other accounting standards agreed by ASX pursuant to Listing Rule 19.11A, the corresponding equivalent standard applies to this report.

  3. Dividends received may be classified either as cash flows from operating activities or cash flows from investing activities, depending on the accounting policy of the entity.

  4. See chapter 19 for defined terms 1 September 2016

Page 5